David A. Fidock

发表

Modeling Within-Host Effects of Drugs on Plasmodium falciparum Transmission and Prospects for Malaria Elimination

David L. Smith, David L. Smith, Simon I. Hay, 2014, PLoS Comput. Biol..

Malaria's Missing Number: Calculating the Human Component of R0 by a Within-Host Mechanistic Model of Plasmodium falciparum Infection and Transmission

David L. Smith, David L. Smith, Geoffrey L. Johnston, 2013, PLoS Comput. Biol..

Diversity-Oriented Synthesis Yields a Novel Lead for the Treatment of Malaria

Menghang Xia, Christopher P. Austin, Michel Weïwer, 2011, ACS medicinal chemistry letters.

Targeting Plasmodium PI(4)K to eliminate malaria

Robert W. Sauerwein, Bruce Russell, David C. Tully, 2013, Nature.

Open-source discovery of chemical leads for next-generation chemoprotective antimalarials

Manuel Llinás, Yingyao Zhou, David A. Fidock, 2018, Science.

Artemisinin resistance phenotypes and K13 inheritance in a Plasmodium falciparum cross and Aotus model

Min Zhang, Juliana M. Sá, Thomas E. Wellems, 2018, Proceedings of the National Academy of Sciences.

Structure and Drug Resistance of the Plasmodium Falciparum Transporter PfCRT

Bridget Carragher, Clinton S. Potter, David A. Fidock, 2020 .

Artemisinin-based combination therapies: a vital tool in efforts to eliminate malaria

David A. Fidock, Richard T. Eastman, D. Fidock, 2009, Nature Reviews Microbiology.

Meister Antimalarial Drug Discovery Liver Stages to Drive Next-Generation Plasmodium Imaging of

Peter G. Schultz, Yingyao Zhou, Jetsumon Sattabongkot, 2012 .

Chloroquine Resistance in Plasmodium falciparum Malaria Parasites Conferred by pfcrt Mutations

David A. Fidock, D. Fidock, Amar Bir Singh Sidhu, 2002, Science.

Erratum: (+)-SJ733, a clinical candidate for malaria that acts through ATP4 to induce rapid host-mediated clearance of Plasmodium (Proceedings of the National Academy of Sciences of the United States of America (2014) 111 (E5455-E5462) 1 DOI: 10.1073/pnas.1414221111)

Anang A. Shelat, Zheng Wang, Jeremy A. Horst, 2015 .

Antimalarial drug discovery: efficacy models for compound screening

David A. Fidock, Philip J. Rosenthal, Solomon Nwaka, 2004, Nature Reviews Drug Discovery.

Drug discovery: Priming the antimalarial pipeline

David A. Fidock, D. Fidock, 2010, Nature.

Spiroindolones, a Potent Compound Class for the Treatment of Malaria

Bruce Russell, David A. Fidock, Elizabeth A. Winzeler, 2010, Science.

Supergenomic Network Compression and the Discovery of EXP1 as a Glutathione Transferase Inhibited by Artesunate

Manuel Llinás, Andreas Martin Lisewski, Olivier Lichtarge, 2014, Cell.

Mitotic Evolution of Plasmodium falciparum Shows a Stable Core Genome but Recombination in Antigen Families

Geoffrey L. Johnston, David A. Fidock, Elizabeth A. Winzeler, 2013, PLoS genetics.

Changes in genome organization of parasite-specific gene families during the Plasmodium transmission stages

William Stafford Noble, Jean-Philippe Vert, David A. Fidock, 2018, bioRxiv.